InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Launches $600 Private Placement of Class A Multiple Voting Shares
Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company focused on innovative biotech assets, announced a non-brokered private placement of class A multiple voting shares (MVS) at $50 per share for gross proceeds of up to $600. The offering is expected to be fully subscribed by existing MVS holders, including entities linked to CEO Zeeshan Saeed and director Anthony Durkacz. As a related-party transaction under MI 61-101, the…